Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: A prospective clinico-pathological study and survival analysis of 70 patients

International Journal of Cancer

Volumn 74, Issue 2, 1997, Pages 212-219

  Lam, King Y ^a,b   Tsao, Sai W ^a   Zhang, Dekai ^a   Law, Simon ^a   He, Dan ^a   Ma, Lily ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030997699     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970422)74:2<212::AID-IJC13>3.0.CO;2-F     Document Type: Article

References (34)

1. ANDREZÉT, M.P., ROBASZKIEWICZ, M., MERCIER, B., NOUSBAUM, J.B., BAIL, J.P., HARDY, E., VOLANT, A., LOZACH, P., CHARLES, J.F., GOUÉRON, H. and FEREC, C., TP53 gene mutation profile in oesophageal squamous cell carcinomas. Cancer Res., 53, 5745-5749 (1993).
2. BEAHRS, O.H., HENSON, D.E., HUTTER, R.V.P. and KENNEDY, B.J., Manual for staging of cancer, pp. 57-59, JB Lippincott, Philadelphia (1992).
3. BENNETT, W.P., HOLLSTEIN, M.C., HE, A., ZHU, S.M., RESAU, J.H., TRUMP, B.F., METCALF, R.A., WELSH, J.A., MIDGLEY, C., LANE, D.P. and HARRIS, C.C., Archival analysis of p53 genetic and protein alterations in Chinese oesophageal cancer. Oncogene, 6, 1779-1784 (1991).
4. CASSON, A.G., MUKHOPADHYAY, T., CLEARY, K.R., RO, J.Y., LEVIN, B. and ROTH, J.A., Oncogene activation in oesophageal cancer. J. Thoracic Cardiovasc. Surg., 102, 707-709 (1991).
5. CHANVITAN, A., NEKARDA, H. and CASSON, A.G., Prognostic value of DNA index. S-phase fraction and p53 protein accumulation after surgical resection of oesophageal squamous-cell carcinomas in Thailand. Int. J. Cancer, 63, 381-386 (1995).
6. ESTÈVE, A., LEHMAN, T., JIANG, W., WEINSTEIN, B., HARRIS, C.C., RUOL, A., PERACCHIA, A., MONTESANO, R. and HOLLSTEIN, M., Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human oesophageal carcinomas. Mol. Carcinogenesis, 8, 306-311 (1993).
7. FURIHATA, M., OHTSUKI, Y., OGOSHI, S., TAKAHASHI, A., TAMIYA, T. and OGATA, T., Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human oesophageal cancer. Int. J. Cancer, 54, 226-230 (1993).
8. GAO, H., WANG, L.D., ZHOU, Q., HONG, J.Y., HUANG, T.Y and YANG, C.S., p53 tumour suppressor gene mutation in early oesophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res., 54, 4342-4346 (1994).
9. GATES, C.E., REED, C.E., BROMBERG, J.S., EVERETT, E.T. and BARON, P.L., Prevalence of p53 mutations in patients with squamous cell carcinoma of the oesophagus. J. Thoracic Cardiovasc. Surg., 108, 148-152 (1994).
10. GOUKON, Y., SASANO, H., NISHIHRA, T., NAGURA, H. and MORI, S., p53 overexpression in human oesophageal carcinoma: a correlation with tumour DNA ploidy and two parameter flow cytometric study. Anticancer Res., 14, 1305-1312 (1994).
11. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumour suppressor gene: clues to cancer aetiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
12. HOLLSTEIN, M.C., PERI, L., MANDARD, A.M., WELSH, J.A., MONTESANO, R., METCALF, R.A., BAK, M. and HOLLSTEIN, Genetic analysis of human oesophageal tumours from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res., 51, 4102-4106 (1991).
13. IMAZEKI, F., OMATA, M., NOSE, H., OHTO, M. and ISONO, K., p53 gene mutations in gastric and oesophageal cancers. Gastroenterology, 103, 892-896 (1992).
14. LAM, K.Y., CHAN, A.C.L., CHAN, K.W., LEUNG, M.L., and SRIVASTAVA, G., Expression of p53 and its relationship with human papillomavirus in penile carcinomas. Europ. J. Surg. Oncol., 21, 613-616 (1995b).
15. LAM, K.Y., LOKE, S.L., CHEN, W.Z., CHEUNG, K.N. and MA, L., Expression of p53 in oesophageal squamous cell carcinoma in Hong Kong Chinese. Europ. J. surg. Oncol., 21, 242-247 (1995a).
16. LAW, S.Y.K., FOK, M., CHENG, S.W.K. and WONG, J., A comparison of outcome after resection for squamous cell carcinomas and adenocarcinomas of the oesophagus and cardia. Surg. Gynecol. Obstet., 175, 107-112 (1992).
17. LEE, S.H., Annual Report from Department of Health, Hong Kong 1990/91, Table 23, Hong Kong Government, Hong Kong (1991).
18. LIANG, Y.Y., ESTÈVE, A., MARTEL-PLANCHE, G., TAKAHASHI, S., LU, S.H., MONTESANO, R. and HOLLSTEIN, M., p53 mutations in oesophageal tumours from high-incidence areas of China. Int. J. Cancer, 61, 611-614 (1995).
19. LUNG, M.L., CHAN, W.C., ZONG, Y.S., TANG, C.M.C., FOK, C.L., WONG, K.T., CHAN, L.K. and LAU, K.W., p53 mutational spectrum of oesophageal carcinomas from five different geographic locales in China. Cancer Epidermiol. Biomarker Prev., 5, 277-284 (1996).
20. MAESAWA, C., TAMURA, G., SUZUKI, Y., OGASAWARA, S., ISHIDA, K., SAITO, K. and SATODATE, R., Aberrations of tumour-suppressor genes (p53, apc, mcc and Rb) in oesophageal squamous-cell carcinoma. Int. J. Cancer, 57, 21-25 (1994).
21. MOK, S.C.H., LO, K.W. and TSAO, S.W., Direct cycle sequencing of mutated alleles detected by PCR single-strand conformation polymorphism analysis. Biotechniques, 14, 790-794 (1993).
22. MONTESANO, R., HOLLSTEIN, M. and HAINAUT, P., Genetic alterations in oesophageal cancer and their relevance to etiology and pathogenesis: a review. Int. J. Cancer, 69, 225-235 (1996).
23. NAKAMURA, T., IDE, H., EGUCHI, R., HAYASHI, K., HANYU, F., NAGASAKO, K., YUKAWA, M., ASAKA, K., FUJIMORI, T. and MAEDA, S., Expression of p53 protein related to human papillomavirus and DNA ploidy in superficial oesophageal carcinoma. Surg. Today, 25, 591-597 (1995).
24. PARKIN, D.M., LAARA, E. and MUIR, C.S., Estimates of the world-wide frequency of sixteen major cancers in 1980. Int. J. Cancer, 41, 184-197 (1988).
25. SARBIA, M., PORSCHEN, R., BORCHARD, F., HORSTMANN, O., WILLERS, R. and GABBERT, H.E. p53 protein expression and prognosis in squamous cell carcinoma of the oesophagus. Cancer, 74, 2218-2223 (1994).
26. SHIBAGAKI, I., TANAKA, H., SHIMADA, Y., WAGATA, T., IKENAGA, M., IMAMURA, M. and ISHIZAKI, K., p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in oesophageal squamous cell carcinoma. Clin. Cancer Res., 1, 769-773 (1995).
27. SHIMAYA, K., SHIOZAKI, H., INOUE, M., TAHARA, H., MONDEN, T., SHIMANO, T. and MORI, T., Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma. Virchows. Archiv. (A. Pathol. Anat.), 422, 271-276 (1993).
28. SOUSSI, T., LEGROS, Y., LUBIN, R., ORY, K. and SCHLICHTHOLZ, B., Multifactorial analysis of p53 alteration in human cancer: a review. Int. J. Cancer, 57, 1-9 (1994).
29. TORNALETTI, S. and PFEIFER, G.P., Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene, 10, 1493-1499 (1995).
30. TSAO, S.W., MOK, C.H., OIKE, K., MUTO, M., GOODMAN, H.M., SHEETS, E.E., BERKOWITZ, R.S., KNAPP, R.C. and LAU, C.C., Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumours. Anticancer Res., 11, 1975-1982 (1991).
31. VIJEYASINGAM, R., DARNTON, S.J., JENNER, K., ALLEN, A., BILLINGHAM, C. and MATTHEWS, H.R., Expression of p53 protein in oesophageal carcinoma: clinicopathological correlation and prognostic significance. Brit. J. Surg., 81, 1623-1626 (1994).
32. WANG, D.Y., XIANG, Y.Y., TANAKA, M., LI, X.R., LI, J.L., SHEN, Q., SUGIMURA, H. and KINO, I., High prevalence of p53 protein overexpression in patients with osophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer, 74, 3089-3096 (1994).
33. WATANABE, H., JASS, J.R. and SOBIN, L.H. and in collaboration with pathologists in eight countries. World Health Organization International histological classification of tumours: histological typing of oesophageal and gastric tumours, pp. 1-8, Springer, Berlin (1990).
34. WYNFORD-THOMAS, D., p53 in tumour pathology: can we trust immunocytochemistry? J. Pathol., 166, 329-330 (1992).